Logo image of ARC.CA

ARCPOINT INC (ARC.CA) Stock Fundamental Analysis

TSX-V:ARC - TSX Venture Exchange - CA03966D1078 - Common Stock - Currency: CAD

0.065  0 (0%)

Fundamental Rating

1

Taking everything into account, ARC scores 1 out of 10 in our fundamental rating. ARC was compared to 16 industry peers in the Health Care Providers & Services industry. ARC may be in some trouble as it scores bad on both profitability and health. ARC does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year ARC was profitable.
ARC had a negative operating cash flow in the past year.
ARC.CA Yearly Net Income VS EBIT VS OCF VS FCFARC.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 5M -5M

1.2 Ratios

ARC has a Return On Assets of 41.70%. This is amongst the best in the industry. ARC outperforms 100.00% of its industry peers.
Industry RankSector Rank
ROA 41.7%
ROE N/A
ROIC N/A
ROA(3y)-46.6%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ARC.CA Yearly ROA, ROE, ROICARC.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 200 -200 400 600 800 1K

1.3 Margins

The Profit Margin of ARC (24.66%) is better than 93.75% of its industry peers.
ARC's Profit Margin has declined in the last couple of years.
With an excellent Gross Margin value of 61.74%, ARC belongs to the best of the industry, outperforming 87.50% of the companies in the same industry.
ARC's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 24.66%
GM 61.74%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-6.24%
PM growth 5YN/A
GM growth 3Y-2.9%
GM growth 5YN/A
ARC.CA Yearly Profit, Operating, Gross MarginsARC.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 50 -50 -100

More info and screens

0

2. Health

2.1 Basic Checks

ARC does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ARC has been increased compared to 1 year ago.
Compared to 1 year ago, ARC has a worse debt to assets ratio.
ARC.CA Yearly Shares OutstandingARC.CA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 10M 20M 30M 40M 50M
ARC.CA Yearly Total Debt VS Total AssetsARC.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

Based on the Altman-Z score of -12.37, we must say that ARC is in the distress zone and has some risk of bankruptcy.
ARC's Altman-Z score of -12.37 is on the low side compared to the rest of the industry. ARC is outperformed by 81.25% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -12.37
ROIC/WACCN/A
WACC5.15%
ARC.CA Yearly LT Debt VS Equity VS FCFARC.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 5M -5M -10M

2.3 Liquidity

ARC has a Current Ratio of 0.09. This is a bad value and indicates that ARC is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of ARC (0.09) is worse than 81.25% of its industry peers.
ARC has a Quick Ratio of 0.09. This is a bad value and indicates that ARC is not financially healthy enough and could expect problems in meeting its short term obligations.
ARC has a Quick ratio of 0.09. This is amonst the worse of the industry: ARC underperforms 81.25% of its industry peers.
Industry RankSector Rank
Current Ratio 0.09
Quick Ratio 0.09
ARC.CA Yearly Current Assets VS Current LiabilitesARC.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 112.99% over the past year.
ARC shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -92.96% yearly.
Looking at the last year, ARC shows a very negative growth in Revenue. The Revenue has decreased by -17.43% in the last year.
Measured over the past years, ARC shows a very negative growth in Revenue. The Revenue has been decreasing by -34.00% on average per year.
EPS 1Y (TTM)112.99%
EPS 3Y-92.96%
EPS 5YN/A
EPS Q2Q%76.49%
Revenue 1Y (TTM)-17.43%
Revenue growth 3Y-34%
Revenue growth 5YN/A
Sales Q2Q%-43.97%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ARC.CA Yearly Revenue VS EstimatesARC.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 5M 10M 15M

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 3.25, which indicates a rather cheap valuation of ARC.
100.00% of the companies in the same industry are more expensive than ARC, based on the Price/Earnings ratio.
ARC is valuated cheaply when we compare the Price/Earnings ratio to 26.29, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 3.25
Fwd PE N/A
ARC.CA Price Earnings VS Forward Price EarningsARC.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ARC.CA Per share dataARC.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 -0.02 0.04 -0.04 -0.06

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ARC!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ARCPOINT INC

TSX-V:ARC (6/2/2025, 7:00:00 PM)

0.065

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners15.2%
Ins Owner ChangeN/A
Market Cap8.34M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 3.25
Fwd PE N/A
P/S 1.11
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)0.02
EY30.77%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS0.06
BVpS-0.07
TBVpS-0.07
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 41.7%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 24.66%
GM 61.74%
FCFM N/A
ROA(3y)-46.6%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-6.24%
PM growth 5YN/A
GM growth 3Y-2.9%
GM growth 5YN/A
F-Score5
Asset Turnover1.69
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0%
Cap/Sales 0%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.09
Quick Ratio 0.09
Altman-Z -12.37
F-Score5
WACC5.15%
ROIC/WACCN/A
Cap/Depr(3y)199.81%
Cap/Depr(5y)N/A
Cap/Sales(3y)6.36%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)112.99%
EPS 3Y-92.96%
EPS 5YN/A
EPS Q2Q%76.49%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-17.43%
Revenue growth 3Y-34%
Revenue growth 5YN/A
Sales Q2Q%-43.97%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y49.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y42.92%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y38.31%
OCF growth 3YN/A
OCF growth 5YN/A